Project Grant HT94252411074
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.007
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The Defense Health Agency awarded a $386,250 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting the validation and inhibition of RHNO1 function in ovarian cancer. The two-year award beginning July 1, 2023 will fund preclinical research efforts to investigate medical solutions for ovarian cancer at the molecular level. As the parent organization, the Board of Regents of the University...
The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
The U.S. Department of the Army Medical Command awarded a $1,460,695 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. This 3-year grant, effective September 1, 2025, supports the development and validation of an epigenomic landscape and novel immunotherapy for prostate cancer disparities. The funding will enable the grantee, a global nonprofit organization dedicated to...
The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
The Defense Health Agency awarded a $1,898,000 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the development of a rapid, fieldable nanopore sequencing-based prognostic and diagnostic assay to advance clinical management decision-making. The 3-year project aims to transform healthcare for military service members and the broader public by...
This federal Project Grant award, valued at $2,041,946.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports a multi-year research initiative led by the San Diego State University Research Foundation to investigate lifestyle and behavioral health interventions. This research aims to transform healthcare for military service members and the broader public by exploring innovative approaches to...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The Regents of the University of California, San Francisco, a prominent academic medical center and research institution, will conduct innovative scientific investigations spanning...
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...